GlucoTrack, Inc.
$0.78
▲
7.5%
2026-04-21 07:01:26
glucotrack.com
NCM: GCTK
Explore GlucoTrack, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.55 M
Current Price
$0.78
52W High / Low
$15.9 / $0.62
Stock P/E
—
Book Value
$3.06
Dividend Yield
—
ROCE
-524.96%
ROE
381.2%
Face Value
—
EPS
$-31.22
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
—
Beta
0.61
Debt / Equity
121.85
Current Ratio
1.61
Quick Ratio
1.61
Forward P/E
—
Price / Sales
—
Enterprise Value
$-2.64 M
EV / EBITDA
0.17
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Short-term liquidity looks comfortable.
Cons
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Avantor, Inc. | $8.5 | — | $5.76 B | — | 5.22% | -9.2% | $16.17 / $7.26 | $8.24 |
| 2. | LeMaitre Vascular, Inc. | $115 | 44.97 | $2.6 B | 0.87% | 11.72% | 15.8% | $118.01 / $78.01 | $17.28 |
| 3. | Femasys Inc. | $0.42 | — | $25.6 M | — | -460.52% | -4.56% | $1.29 / $0.31 | $0.1 |
| 4. | Nephros, Inc. | $3.07 | 27.37 | $32.68 M | — | 10.54% | 12.71% | $6.42 / $1.64 | $0.96 |
| 5. | Lucyd, Inc | $1.07 | — | $6.68 M | — | -93.41% | -83.6% | $4.97 / $0.95 | $1.65 |
| 6. | Alcon Inc. | $77.24 | — | $30.37 B | 0.45% | 4.77% | 4.5% | $81.92 / $56.44 | $45.2 |
| 7. | Warby Parker Inc. | $25.89 | 1,889.51 | $3.1 B | — | -0.93% | 0.46% | $31 / $13.63 | $3 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -3.49 M | -4.31 M | -4.8 M | -3.5 M | -3.85 M | — |
| Net Profit | -3.63 M | -4.17 M | -4.76 M | -6.83 M | -10.09 M | — |
| EPS in Rs | -1.87 | -2.15 | -2.45 | -3.51 | -5.19 | -1,092 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -16.09 M | -14.55 M | -7.1 M | -4.43 M |
| Net Profit | -19.39 M | -22.6 M | -7.1 M | -4.43 M |
| EPS in Rs | -9.97 | -11.62 | -3.65 | -2.28 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 7.84 M | 5.93 M | 4.91 M | 2.44 M |
| Total Liabilities | 5.01 M | 18.93 M | 1.71 M | 1.21 M |
| Equity | 2.83 M | -13 M | 3.2 M | 1.23 M |
| Current Assets | 7.67 M | 5.77 M | 4.87 M | 2.38 M |
| Current Liabilities | 4.77 M | 1.27 M | 1.51 M | 1.01 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -15.24 M | -12.49 M | -6.56 M | -3.73 M |
| Investing CF | -0.1 M | -0.1 M | 0 M | 0 M |
| Financing CF | 17.04 M | 13.74 M | 8.73 M | 0 M |
| Free CF | -15.34 M | -12.59 M | -6.56 M | -3.73 M |
| Capex | -0.1 M | -0.1 M | — | -0 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | -218.4% | -60.02% | — | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-06-16 | 1:0.0166667 |
| 2025-02-04 | 1:0.05 |
| 2024-05-20 | 1:0.2 |
| 2021-08-13 | 1:0.0769231 |